ChenGuang Biotech Group Co., Ltd.

SZSE:300138 Stok Raporu

Piyasa değeri: CN¥4.2b

ChenGuang Biotech Group Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 1/6

ChenGuang Biotech Group has been growing earnings at an average annual rate of 12.3%, while the Food industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 17.1% per year. ChenGuang Biotech Group's return on equity is 3.7%, and it has net margins of 2.2%.

Anahtar bilgiler

12.3%

Kazanç büyüme oranı

10.9%

EPS büyüme oranı

Food Sektör Büyümesi7.2%
Gelir büyüme oranı17.1%
Özkaynak getirisi3.7%
Net Marj2.2%
Son Kazanç Güncellemesi30 Sep 2024

Yakın geçmiş performans güncellemeleri

Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)

Apr 25
Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)

Recent updates

A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb

Oct 08
A Piece Of The Puzzle Missing From ChenGuang Biotech Group Co., Ltd.'s (SZSE:300138) 43% Share Price Climb

ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively

Sep 30
ChenGuang Biotech Group (SZSE:300138) Might Be Having Difficulty Using Its Capital Effectively

Return Trends At ChenGuang Biotech Group (SZSE:300138) Aren't Appealing

May 13
Return Trends At ChenGuang Biotech Group (SZSE:300138) Aren't Appealing

Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)

Apr 25
Impressive Earnings May Not Tell The Whole Story For ChenGuang Biotech Group (SZSE:300138)

ChenGuang Biotech Group Co., Ltd. (SZSE:300138) Just Reported, And Analysts Assigned A CN¥17.66 Price Target

Apr 21
ChenGuang Biotech Group Co., Ltd. (SZSE:300138) Just Reported, And Analysts Assigned A CN¥17.66 Price Target

Gelir ve Gider Dağılımı

ChenGuang Biotech Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.


Kazanç ve Gelir Geçmişi

SZSE:300138 Gelir, gider ve kazançlar (CNY Millions )
TarihGelirKazançlarG+A GiderleriAr-Ge Giderleri
30 Sep 246,927150-1411
30 Jun 246,694287-110
31 Mar 246,786389-45
31 Dec 236,87248600
30 Sep 236,66949622692
30 Jun 236,737492237113
31 Mar 236,529462243129
31 Dec 226,296434249129
30 Sep 226,465429255135
30 Jun 226,002403244116
31 Mar 225,44638022899
31 Dec 214,87435221195
30 Sep 214,41032219088
30 Jun 214,18630418991
31 Mar 214,18828516583
01 Jan 213,91326819283
30 Sep 203,66725221168
30 Jun 203,48123523148
31 Mar 203,28820628152
31 Dec 193,26519426949
30 Sep 193,22616527245
30 Jun 193,37816225443
31 Mar 193,13914623234
01 Jan 193,06314521829
30 Sep 182,79915518726
30 Jun 182,77915915342
31 Mar 182,80715514035
31 Dec 172,77214315229
30 Sep 172,78012918921
30 Jun 172,3841202090
31 Mar 172,2591112110
31 Dec 162,141921910
30 Sep 161,824991410
30 Jun 161,636791220
31 Mar 161,474801090
31 Dec 151,268691000
30 Sep 151,24659970
30 Jun 151,28757960
31 Mar 151,20524950
31 Dec 141,20722920
30 Sep 141,23821880
30 Jun 141,1744900
31 Mar 141,1313990
31 Dec 131,186101030

Kaliteli Kazançlar: 300138 has a large one-off loss of CN¥91.3M impacting its last 12 months of financial results to 30th September, 2024.

Büyüyen Kar Marjı: 300138's current net profit margins (2.2%) are lower than last year (7.4%).


Serbest Nakit Akışı ve Kazanç Analizi


Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: 300138's earnings have grown by 12.3% per year over the past 5 years.

Büyüme Hızlandırma: 300138's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Kazançlar vs. Sektör: 300138 had negative earnings growth (-69.8%) over the past year, making it difficult to compare to the Food industry average (-6%).


Özkaynak Getirisi

Yüksek ROE: 300138's Return on Equity (3.7%) is considered low.


Varlık Getirisi


Kullanılan Sermaye Getirisi


Geçmişte güçlü performans gösteren şirketleri keşfedin